CARBONIC ANYDRASE INHIBITORS
- 總結
- Carbonic anhydrase inhibitors and their use as chemosensitizing agents in the treatment of cancers
- 技術優勢
- These compounds can potentially be useful in treating resistant cancers such as glioblastoma, by revesring the resistance to currently used drugs
- 技術應用
- Cancer therapy
- 詳細技術說明
- Compounds are provided which are inhibitors of the CAXII enzyme. Due to the interaction between CAXII and Pgp, such compounds may be useful in lowering the chemoresistance of a cancer allowing for co-treatment with existing anti-cancer agents.
- 合作類型
- Licensing
- 申請日期
- 12/05/2017 00:00:00
- 申請號碼
- 2017203184
- 國家/地區
- 澳洲
欲了解更多信息，請點擊 這裡
